Similar Articles

Browse Main Topics:

Business
Computers & Electronics
Education & Reference
Entertainment & Leisure
Family & Home
Finance & Investment
Health
Internet
Pets & Animals
Science & Technology
Society, Politics & Culture
Sports & Recreation

Similar Articles

The Motley Fool September 29, 2011 Shubh Datta	It's Buyback Time at Coca-Cola Enterprises Coca-Cola Enterprises plans to buy back $1 billion worth of its shares.
The Motley Fool June 14, 2007 Nathan Parmelee	Target Releases Arrows Made of Money The retailer has done well by shareholders, and might do even better.
The Motley Fool March 6, 2008 Rich Smith	Juniper's Billion-Buck Buyback But who will reap the rewards?
The Motley Fool November 25, 2009 Brian Orelli	A Schizophrenic Move by Merck? Issue $29 billion in shares, buy back $3 billion. Say what? Merck increased its share count by almost 45% to pay for the acquisition of Schering-Plough. Now it's planning to buy some of that stock back.
The Motley Fool December 7, 2006 Seth Jayson	Bad Advice on Buybacks The point of a buyback is not to "move" the stock -- not over the short term. The point of a buyback is to increase shareholder value in the long run by giving existing shareholders a bigger cut of future economic benefits.
The Motley Fool December 1, 2009 Selena Maranjian	Is Hewlett-Packard Crazy? Hewlett-Packard recently announced that its future is looking brighter and it's tripling its planned share repurchases, upping the limit to $12 billion worth of stock. Is it a good move?
The Motley Fool September 21, 2011 Alex Dumortier	Dell: Compounding or Destroying Value? Dell's share buyback program looks like a good use of shareholder capital. In fact, I think it's worth adding Dell to your watchlist.
The Motley Fool March 6, 2009 Brian Orelli	Why the Buyback, Intuitive Surgical? Buybacks for high-growth companies like Intuitive Surgical aren't such a bad idea anymore.
The Motley Fool September 28, 2011 Alex Dumortier	Edwards Lifesciences: Creating or Destroying Value? With shares trading at 33.2 times its earnings-per-share estimate for the next 12 months, the share buyback program looks like a poor use of shareholder capital at these prices.
The Motley Fool December 26, 2007 Rich Smith	Northrop's $2.5 Billion Buyback Northrop Grumman announces a buyback authorization of truly mammoth proportions. At $2.5 billion in size, this buyback could potentially reduce Northrop's share count by approximately 9% if implemented in full.
The Motley Fool October 5, 2011 Shubh Datta	At Walgreen, It's Payback Time Walgreen buys back shares and raises its dividend.
The Motley Fool September 21, 2011 Alex Dumortier	Kroger: Compounding or Destroying Value? Management is spending your capital.
The Motley Fool September 28, 2011 Alex Dumortier	Lockheed Martin: Creating or Destroying Value? With shares trading at 9.3 times its earnings-per-share estimate for the next 12 months, the share buyback program looks like an acceptable use of shareholder capital at these prices.
The Motley Fool October 3, 2011 Harsh Chauhan	Why This Stock Looks Like a Buy Authorization of another buyback bodes well for Cypress.
The Motley Fool April 24, 2008 Brian Orelli	Illumina Ignites This biochip maker is on fire.
The Motley Fool October 28, 2008 Rich Duprey	Don't Buy the Buyback Hype Are share buybacks little more than a tool for management to massage earnings? As for the benefit to individual shareholders, is it all it's cracked up to be?
The Motley Fool October 22, 2008 Tim Beyers	Oracle Blows Billions The database company's board says it will up its stock buyback program by $8 billion, presumably financed through free cash flow.
The Motley Fool September 23, 2011 Alex Dumortier	Staples: Compounding or Destroying Value? With shares trading at just 9.1 times its earnings-per-share estimate for the next 12 months, Staples' share buyback program looks like a very good use of shareholder capital.
The Motley Fool September 30, 2011 Alex Dumortier	Raytheon: Compounding or Destroying Value? With shares trading at 7.6 times its earnings-per-share estimate for the next 12 months, the share buyback program looks like a good use of shareholder capital at these prices.
The Motley Fool June 17, 2011 Shubh Datta	Why I Love Ebix's $75 Million Buyback Program The software and e-commerce solutions provider plans to buyback nearly $75 million worth of shares.
The Motley Fool September 30, 2011 Alex Dumortier	Accenture: Creating or Destroying Value? With shares trading at 14.3 times its earnings-per-share estimate for the next 12 months, the share buyback program looks like a decent use of shareholder capital at these prices.
The Motley Fool September 26, 2011 Alex Dumortier	Flowserve: Compounding or Destroying Value? Based on its price-to-earnings ratio, Flowserve trades toward the bottom of the range against four of its competitors.
The Motley Fool June 10, 2008 Brian Lawler	Buy Back Shares, Then Issue More? Investors marvel at what seems like temporary financial schizophrenia from American Oriental Bioengineering.
InternetNews August 25, 2005 Paul Shread	HP Boosts Buyback HP announced plans to buy back an additional $4 billion in stock late Thursday... Oil prices stabilized... The broader markets edged higher... TiVo plunged 15% on reduced expectations... etc.
The Motley Fool April 22, 2009 Brian Orelli	Illuminating Stock Option Problems Illumina's stock options are getting a little ridiculous. This problem was pointed out in the third quarter last year, and it doesn't seem to be going away.
The Motley Fool July 24, 2008 Brian Orelli	Illumina Polishes Its Biochips There's very little to complain about in Illumina's earnings report. In this market, you'll see few investors grumbling about double-digit growth.
The Motley Fool October 14, 2011 Harsh Chauhan	Looking Beyond Dell's Buyback Would it be wiser for Dell to spend money on R&D rather than buybacks?
The Motley Fool July 1, 2011 Shubh Datta	It's Buyback Time at Best Buy The retailer plans to repurchase nearly $5 billion worth of shares.
The Motley Fool February 4, 2009 Brian Orelli	43% Growth! Yee-Haw! Illumina rocks another quarter.
The Motley Fool June 15, 2007 Rich Smith	Staples Secures Shares Wall Street's buyback binge continues. Staples had a $1.5 billion buyback plan in place already, but it had burned through $1.2 billion of its authorization and decided a re-up was in order.
The Motley Fool July 22, 2009 Brian Orelli	Levering the Genome Lower revenue can't stop Illumina from turning in a good bottom line.
The Motley Fool October 10, 2005 Mike Cianciolo	Staples Sticks to Outlook The office supply leader affirms its outlook and announces a stock buyback.
The Motley Fool August 6, 2008 Brian Orelli	Illumina Grabs Some Cash With biochip maker Illumina hitting 52-week highs, it seems inevitable that the company would do a secondary offering to grab some cash -- about $300 million, as it turns out.
The Motley Fool October 28, 2009 Brian Orelli	Ugly, but Still Built for Growth It continues to be a tale of two business segments for Illumina, with sales from the consumables used in its sequencing machines more than doubling, while its array business remains down considerably.
The Motley Fool October 27, 2011 Alex Dumortier	Don't Buy Into People's United's Buyback People's United's new buyback program doesn't mean you should buy.
The Motley Fool September 28, 2011 Alex Dumortier	Aetna: Creating or Destroying Value? With shares trading at 8.7 times its earnings-per-share estimate for the next 12 months, the share-buyback program looks like a good use of shareholder capital at these prices.
The Motley Fool January 11, 2011 Esterhuizen & Sellitti	Undervalued Companies Buying Back Their Own Stock How do you know when a stock is undervalued?
The Motley Fool September 9, 2010 Rich Smith	Tyco Tries a Billion-Buck Buyback Can it pay? Sure. But should it?
The Motley Fool December 12, 2007 Rich Smith	General D's Below-Billion-Buck Buyback Defense contracting giant General Dynamics announces a 10-million-share repurchase authorization; at current share prices this represents an almost billion-dollar buyback. Can the company afford it? And even if it can, should it?
InternetNews July 20, 2004 Erin Joyce	Microsoft To Buy Back $30B In Stock Microsoft moved to significantly boost the value of its shares Tuesday, as it announced a quarterly dividend of 8 cents per share as well as plans to buy back up to $30 billion of its own stock over the next four years.
The Motley Fool October 10, 2011 Alex Dumortier	Don't Buy Into Pall's Share Buyback Purification and filtration products manufacturer Pall's new buyback program is no "buy" indicator.
The Motley Fool April 29, 2011 Brian Orelli	Show Us the Money, Drugmakers Drugmakers have cash and they aren't afraid to use it -- on themselves.
The Motley Fool August 22, 2007 Rich Smith	Nordstrom Doubles Down Fresh from completing its last buyback of $1 billion worth of shares, the retailer announced that it's digging into its purse for another $1.5 billion worth of spare change with which to finance a shopping spree on its own shares.
The Motley Fool December 8, 2004 Rich Duprey	Buybacks Can Predict Profits Use management's signal flag of an undervalued stock to make market-beating profits.
The Motley Fool October 4, 2011 Abantika Chatterjee	Easier Said Than Done at Rockwell Collins Will a buyback be a good strategy to boost EPS?
The Motley Fool July 28, 2010 Brian Orelli	Now There's an Illuminating Idea Helping your customers sell more of your product makes a lot of sense.
The Motley Fool October 31, 2011 Alex Dumortier	Should Monster Be Buying Back Shares? The CEO says the stock is "an excellent investment." Is it?
The Motley Fool September 8, 2011 Shubh Datta	It's Buyback Time at Acxiom Data services company Acxiom is planning to buy back up to $50 million worth of its stock in a move that CEO Scott Howe says is "an appropriate use of cash" at present. But is that all there is to it?
The Motley Fool February 3, 2005 Ben McClure	Tellabs Is Listening But is a buyback enough to keep the telecom company's investors happy?
The Motley Fool February 28, 2011 Brian Orelli	Pharma's Newest Acquisition Targets Share buybacks are in at big pharma companies. Does it mean that licensing deals are out?